Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia

Clinical trial NCT05213104 · UNKNOWN

Trial details

NCT number: NCT05213104
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Patent Foramen Ovale Atrial Arrhythmia Cryptogenic Stroke

Start date: 2022-03-23
Primary completion: 2024-02-28
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.